The management need to show the market their ability to make money out of their products. They might have the best technologiy scope in the world but if the management can't make money out of it then nobody will be interested in the company. Keep talking how good is the product without real value created is useless. Zeiss convivo is fda approved and in the market for almost 2 years now and the revenue generated for optiscan is just merely 500k aud. We could see the same thing happen to invivage after the fda approved. Is a shame if you have the best product in the world but you can't make money out of it
- Forums
- ASX - By Stock
- Good read
The management need to show the market their ability to make...
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $133.6M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $14.74K | 91.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49973 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 43713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49973 | 0.160 |
4 | 119641 | 0.155 |
6 | 61826 | 0.150 |
1 | 30000 | 0.145 |
4 | 111133 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 11713 | 1 |
0.170 | 50000 | 1 |
0.175 | 61821 | 2 |
0.180 | 32743 | 3 |
0.190 | 4375 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |